Get my own profile
Public access
View all128 articles
10 articles
available
not available
Based on funding mandates
Co-authors
- Paul GeurinkAssistant professor, LUMCVerified email at lumc.nl
- Jacques NeefjesHoogleraar cell biologie en immunologie, Leiden UniversiteitVerified email at nki.nl
- Hidde PloeghSenior Investigator, Program in Cellular and Molecular Medicine, Boston Children's HospitalVerified email at childrens.harvard.edu
- Ton N.M. SchumacherThe Netherlands Cancer Institute, Third Rock VenturesVerified email at nki.nl
- H.S. OverkleeftProfessor of Bio-organic Synthesis, Leiden UniversityVerified email at lic.leidenuniv.nl
- Benedikt KesslerProfessor of Biochemistry and Life Science Mass Spectrometry, University of Oxford, UKVerified email at ndm.ox.ac.uk
- Reggy EkkebusNetherlands Cancer InstituteVerified email at nki.nl
- David KomanderUbiquitin Signalling Division, Walter and Eliza Hall Institute of Medical Research, MelbourneVerified email at wehi.edu.au
- Dharjath S HameedPost-Doc, LUMC LeidenVerified email at lumc.nl
- Alfred VertegaalLeiden University Medical CenterVerified email at lumc.nl
- Titia K. SixmaDivision of Biochemistry, Netherlands Cancer Institute, AmsterdamVerified email at nki.nl
- Ilana BerlinLUMCVerified email at lumc.nl
- Albert J. R. HeckBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center and Utrecht UniversityVerified email at uu.nl
- Anastassis PerrakisDivision of Biochemistry, Netherlands Cancer Institute and Oncode Institute, Prof Utrecht UVerified email at nki.nl
- Yogesh KulathuMRC Protein Phosphorylation & Ubiquitylation Unit, University of DundeeVerified email at dundee.ac.uk
- Lennert JanssenVerified email at lumc.nl
- Tycho E.T. Mevissen, PhDHarvard Medical SchoolVerified email at hms.harvard.edu
- Laurens A van MeeterenUtrecht UniversityVerified email at uu.nl
- Patrick CelieProtein Facility Manager at The Netherlands cancer Institute (NKI)Verified email at nki.nl
- Dmitri V. FilippovLeiden UniversityVerified email at chem.leidenuniv.nl